• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Outcomes of COVID-19-related ARDS patients on extracorporeal membrane oxygenation

byConstance Wu
October 27, 2020
in StudyGraphics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Patients with COVID-19-related acute respiratory distress syndrome (ARDS) had a comparable 90-day mortality rate to those with non-COVID ARDS on extracorporeal membrane oxygenation (ECMO).

2. Higher patient age, higher PaO2:FiO2 ratio and presence of significant acute or chronic disease were all associated with greater risk of mortality in COVID-19 patients on ECMO.

Evidence Rating Level: 2 (Good)

Study Rundown: SARS-CoV-2, the causative agent of COVID-19, has burdened health systems worldwide. Part of the difficulty in treating the illness is its broad spectrum of presentation. In its most extreme form, COVID-19 can cause acute respiratory distress syndrome (ARDS), which bears a particularly poor prognosis. The World Health Organization and Surviving Sepsis Campaign have both recommended extracorporeal membrane oxygenation (ECMO) for patients with COVID-19-related ARDS in which lung protective mechanical ventilation has failed. Despite this recommendation, early data suggested that ECMO might, in fact, be harmful to patients with COVID-19-related ARDS, and increase mortality. This retrospective cohort study utilized data from the international Extracorporeal Life Support Organization (ELSO) database to analyze the mortality rate associated with COVID-19-related ARDS patients on ECMO. Overall, in-hospital mortality at 90 days for COVID-19 patients had an estimated cumulative incidence comparable to that of non-COVID-19 patients with ARDS on ECMO (38.0%). A total of 57% of patients were discharged alive from the hospital. Several factors were associated with higher overall mortality on ECMO, including increased age, higher PaO2:FiO2 ratio, and presence of several significant medical conditions (acute kidney injury, chronic respiratory insufficiency, previous cardiac arrest, among others). A major strength of this study is the use of a large, international database to analyze mortality on ECMO. Importantly, however, given that it is not a randomized, controlled trial, no definitive statements can be made about the use of ECMO in COVID-19-related ARDS based on these results. Other limitations included the fact that the authors did not independently validate the information provided by the ELSO database; additionally, only 79% of patients in their cohort had actually been identified as having ARDS as per the Berlin criteria.

Click to read the study in The Lancet

Relevant reading: Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19

In-Depth [retrospective cohort]: This international, multicenter, retrospective cohort study analyzed ELSO data from 1093 patients aged over 16 years old at 213 centers in 36 countries across the world. Eligible patients had confirmed COVID-19 and were placed on ECMO. The median age was 49 years (IQR 41-57) and 74% were men. The majority had ARDS as defined by the Berlin criteria (79% of patients), and most were put on venovenous ECMO (94%). The primary outcome of the study was in-hospital death at 90 days after beginning ECMO; secondary outcomes included proportion of patients remaining in the intensive care unit (ICU) at 90 days, those discharged from ICU but remaining in hospital, discharged to home, or discharged to long-term acute care center. Overall, the estimated cumulative incidence of mortality in hospital at 90 days after initiative ECMO was 37.4% (95% CI 34.4-30.4), a rate comparable to mortality rates in patients with non-COVID-19-ARDS and acute respiratory failure on ECMO. In a subset of patients with COVID-19-related ARDS and receiving venovenous ECMO, mortality was 38.0% (95% CI 34.6-41.5). A total of 588 patients (57%) were discharged alive from hospital; 311 (30%) to an acute rehabilitation center, 101 (10%) to a long-term acute care center or unspecific, and 176 (17%) to another hospital. The results of this study, although not yet supported by a randomized, controlled trial, point towards ECMO as being a reasonable treatment option in COVID-19-relarted ARDS once mechanical ventilation has failed.

RELATED REPORTS

Unvaccinated status increases risk of long COVID symptoms

The 2 Minute Medicine Podcast Episode 6

The Scan by 2 Minute Medicine®: the Future of Medicine, Neuralink, the Spotlight on Celine Dion and COVID-19 on Social Media

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: acute respiratory distress syndrome (ARDS)Coronavirusextracorporeal membrane oxygenation (ECMO)SARS-CoV-2
Previous Post

Evolocumab successfully reduced LDL levels in pediatric patients

Next Post

Altered acylcarnitine metabolism associated with increased risk of atrial fibrillation

RelatedReports

Medical vaccine exemptions increase after elimination of nonmedical exemptions
Infectious Disease

Unvaccinated status increases risk of long COVID symptoms

January 25, 2023
2MM Podcast

The 2 Minute Medicine Podcast Episode 6

January 13, 2023
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: the Future of Medicine, Neuralink, the Spotlight on Celine Dion and COVID-19 on Social Media

December 27, 2022
Medical vaccine exemptions increase after elimination of nonmedical exemptions
Cardiology

Slight increase of incidence of myocarditis post-mRNA SARS-CoV-2 vaccination

December 15, 2022
Next Post
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source

Altered acylcarnitine metabolism associated with increased risk of atrial fibrillation

#VisualAbstract: Drug-eluting stents for saphenous vein grafts associated with better outcomes than bare-metal stents

#VisualAbstract: Drug-eluting stents for saphenous vein grafts associated with better outcomes than bare-metal stents

Amniotic fluid lactate associated with labor disorders

COVID-19 infection in late pregnancy associated with adverse birth outcomes

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
  • Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease
  • Homicide deaths are on the rise for children living in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options